IRWD

Ironwood Pharmaceuticals Stock Analysis

AI Rating

Good
  • Quality8/10
  • Growth↓ 4/10
  • Momentum↑ 9/10
Ironwood Pharmaceuticals sales and earnings growth
IRWD Growth
Neutral
  • Revenue Y/Y↓ -10.42%
  • EPS Y/Y↑ 1050.00%
  • FCF Y/Y↓ -45.36%
Ironwood Pharmaceuticals gross and profit margin trends
IRWD Profitability
Good
  • Gross margin ↑ 100.00%
  • EPS margin↓ 8.40%
  • ROIC↑ 18.10%
Ironwood Pharmaceuticals net debt vs free cash flow
IRWD Risk
Great
  • Debt / Equity↓ -2.3
  • Debt / FCF↑ 6.8
  • Interest coverage↓ 3.8

Ironwood Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Drug Manufacturers - Specialty & Generic stocks ↗